DAVID GRANOVSKY

Anecdotal – The Dirty Word in Gordie Howe’s Stem Cell Treatment

In ALL ARTICLES on February 10, 2015 at 7:35 pm

What does it tell you when expert after expert tries to discredit the results of Gordie Howe’s stem cell treatment while his son Dr. Murray Howe, chairman of Toledo Hospital’s department of radiology, credits the stem cells for his recovery?

Dr. Murray Howe is the chairman of Toledo Hospital's department of radiology.

Dr. Murray Howe is the chairman of Toledo Hospital’s department of radiology.

What does it tell you when expert after expert claim his recovery and improvements are insignificant…while simultaneously attributing his recovery and improvements to everything except the stem cells he received?

What does it tell you when expert after expert discredits the anecdotal evidence of Gordie Howe’s recovery as “merely anecdotal” while it is actually one mere drop in an ocean of tens of thousands per year who have improved from cancer with cellular therapies over the last 59 years and tens of thousands who have improved over the past 12-14 years from non-cancer conditions?

And what is the value of this huge array of empirical and anecdotal evidence?

Gordie Howe Recovers From Stroke with Stem Cells

Gordie Howe Recovers From Stroke with Stem Cells

There are many types of evidence, not just trials or anecdotal.  Too often we reduce the evidential options to either clinical trials or anecdote.  Wrong.  That’s 5 blind men describing an elephant all over again.  We must take into account ALL of the different types of evidence and only THEN we can make a judgment based on the cumulative evidential data.

Anecdotal Evidence – Peyton Manning, Kobe Bryant, Rafael Nadar, Bartolo Colon…athletes from major sports organizations all over the world are embracing and anecdotally illustrating the safety and efficacy of cellular therapies

Statistical Evidence – 50,000 patients per year… are statistically illustrating the safety and efficacy of cellular therapies

Testimonial Evidence – Youtube is chock full of testimonies of athletes and patients who are benefiting from cellular therapies and via testimonial, illustrating the safety and efficacy of cellular therapies

Analogical Evidence – 59 years and thousands of trials and studies are analogously illustrating the safety and efficacy of cellular therapies

Clinical Trial evidence – Even though it may be the wrong process to evaluate cellular therapies, the vast majority of over 2,400 clinical trials are scientifically and empirically illustrating the safety and efficacy of cellular therapies

Miracle results? No.  This is par for the course results from real expectations based on the multitude of evidence types collected over the past six decades for cellular therapies.  The combined patchwork of all of the data from all of these evidences paints a very compelling conclusion.

Are cellular therapies safe and effective?  All of the evidences seem to say so.  Not just the anecdotal evidence;
anecdotal,
statistical,
testimonial,
analogical
and clinical trial evidences.

by David Granovsky, Stem Cell Writer and Author

Read one of the many myopically evidential articles here: http://www.theglobeandmail.com/globe-debate/the-stem-cell-miracle-is-anecdotal/article22880977/

SHOULD STEM CELLS BE USED ONLY AS A LAST RESORT?

In ALL ARTICLES on January 12, 2015 at 1:49 pm

https://i2.wp.com/upload.wikimedia.org/wikipedia/commons/e/e8/Last_Resort_Logo_Noir.png

Should stem cells be used only as a last resort? 

Two reasons why the answer is NO!

1.  Last week I saw someone with no education on stem cells stating that stem cells should be used only as a last resort.
The presentation of stem cell therapies as a last resort is tragic. Unfortunately, most people do come to me asking for information as a last resort.  They have been advised by their friends, family, medical professionals and media that they should try everything else and not try stem cells.  When all else fails and they finally approach me, “I’ve tried everything,” is a common explanation. Again, tragic. In many cases, the sooner stem cells are used, the faster patients can improve their quality of life, relieve their suffering and mediate their symptoms.
The CEO of a well known stem cell company made this analogy: “Most people renovate their homes just before selling them.  What a missed opportunity!  If they renovated them earlier they would derive years of pleasure from the renovation instead of fixing things up for the next owner.”  But what if you used stem cell therapies to improve your health and fix your body BEFORE you exhausted all other resources, money, energy, your immune system and your health?   What a concept.
2.  A new study is investigating the question: Is stem cell therapy less effective in older patients with chronic diseases?
Let’s over-simplify…
When was the last time a piece of equipment in your car failed and another one didn’t fail soon after.  This is because they are dependent upon each other for optimum efficiency.  The older the patient and the more advanced their disease, the odds are, the more there are other organs and systems being taxed beyond their capabilities.  And many people believe one pill will fix their disease but it’s far from true.  We must change the one pill for one one disease, one size fits all, magic cure belief which is rampant in the USA.  There is no evidence to support it.
Look at it another way.  Consider your body a battleground and the disease is the enemy.  The surest way to fight the enemy is to send wave after wave of soldiers (stem cells) into battle.  But many of the same issues in battle restrict maximizing the success of your therapy.  If you cut off the supply routes to the soldiers carrying food and ammunition (a weakened or restricted circulatory system), your soldiers’ ability to move to the battle will be ineffective.  If you wipe out their communications (cytokines/messenger cells), your soldiers won’t know where to go or what is needed to fight.
Time is always against us.  The longer we wait, the more our resources will be depleted and our other organs and systems will be taxed, both to support the failing areas and due to the natural deterioration associated with aging.  “Aging and chronic diseases including CVD and diabetes substantially affect stem/progenitor cells of adult organism. Such conditions could restrict the effectiveness of autologous cell therapy in aged patients with CAD, lower limb ischemia, T2DM and other chronic pathologies, although these patients are some of the most obvious candidates for cell therapy.”

Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells – http://online.liebertpub.com/doi/full/10.1089/biores.2014.0042

It is my hope that people do real research or talk to someone who has so they can make an educated decision about reclaiming their health. There is a great deal of misinformation out there and many people are trying to sabotage the real info and data getting to those whom need it most. Let’s work together to get rid of misinformation and not perpetuate the confusion which may lead to unnecessary suffering.  DON’T WAIT.

LORI MILLS WINS BATTLE WITH BLUE CROSS IN WAR ON CIDP

In ALL ARTICLES, BUSINESS OF STEM CELLS, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on January 9, 2015 at 8:08 pm

“A journey of a thousand miles begins with a single step.”Lao-tzu,

Lori Mills’ story is now mainstream and may affect millions of people in years to come.  You may have seen her in the dictionary under “persistence” or next to the quote: “be the change you want to see in the world.”  Certainly she is a very lucky woman.  Or maybe it’s simpler than that.  Maybe she is simply a mother and a wife who wants to live her life as best as she can without simultaneously carrying the burden of a debilitating illness.

Lori has chronic inflammatory demyelinating polyneuropathy or CIDP and she was denied insurance coverage by Blue Cross Blue Shield in the Summer of 2014.  One week ago, believe it or not, they reversed their decision. This is a huge victory for Lori in the battle with Blue Cross Blue Shield.  This is also the first of many skirmishes in her war on CIDP and a minor victory for those that follow her.  Here’s how it breaks down:

  • Be excited for Lori as she now has a chance at a better life.  She has defeated the one thing standing in her way of getting treated.
  • Don’t expect insurance companies to start caving tomorrow as BCBS has already stated with conviction that this is not to be seen as a precedent.
  • The treatment she is approved for is a clinical trial with exclusionary criteria, not from a treatment center so this is not available to the general public.

I reached out to Lori today and both she and her friends responded with grace and respect:

Hi Lori,
I’m following your story with great interest. I am a 10 year stem cell educator and while Blue Cross is clear in stating that this shouldn’t be considered precedent setting I just wanted to personally thank you for your hard work to get the doors open just a little bit more for those people who are suffering needlessly with conventional drug and treatment protocols which do not work for them. Kudos to you and yours! Wishing you the best,
David

We wish her great success and hope to do a follow up on her progress at the end of her trial.

————————-

I’d like to share something with you.  Look at the image below.  It jumped out at me.
A simple statement.  “I’m a CIDP Fighter.”
We can all understand what it means to fight a single adversary.
With awareness and education we can learn what it means to fight an invisible neurological illness like CIDP.
And that should be enough.  For anyone.  But it isn’t.

Today’s patients seek answers, seek cures, seek stem cell therapies…
but they are not just fighting their conditions…
they often are simultaneously fighting the medical establishment, fighting insurance companies, fighting ignorance and fighting resistance.
It should not be this hard.  We should do more to make it easier for patients to get the treatments they need.  We must do more.

https://i2.wp.com/api.ning.com/files/g3sZFdca7acig06FeFWUZqdRPlquxI2mTDs9uAFPDyLXkzcpRZ7I43vUcRg17SeZXVckqdfYklRANSSUHPFwBNvR9VB6NnHt/603671_10102191952132385_769765818_n1.jpg

Blue Cross overturns decision, approves stem cell transplant coverage

GREENVILLE, Mich. — Lori Mills has been approved to receive a stem cell transplant under her Blue Cross Blue Shield coverage.

The insurance company has overturned its previous denial from the summer of 2014.

In a letter Mills received January 2, 2015, Blue Cross states the company will now pay for the potentially life-changing procedure.

“I know it’s going to be a shot at a whole new life for me,” Mills said today.

She added, “I know that because of our previous interview, it really helped get this approval letter because whenever I call they talk about it.”

FOX 17 also interviewed Mills in October, questioned Blue Cross, and aired her story.

She suffers from chronic inflammatory demyelinating polyneuropathy or CIDP. Her immune system attacks her nervous system. She shakes, has numbness, and it impairs her movement.

Doctors told her a stem cell transplant could be the cure.

via

RELATED ARTICLES:

NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDP

http://www.neurology.org/content/69/18/1802.short

Haemopoietic stem cell transplantation—an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology

http://www.maneyonline.com/doi/abs/10.1080/10245330701255106

Autologous haemopoietic stem cell transplantation for autoimmune diseases
http://informahealthcare.com/doi/abs/10.1517/14712598.2011.580272

Follow

Get every new post delivered to your Inbox.

Join 3,336 other followers

%d bloggers like this: